Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Related Research Data
Bisphosphonates: therapeutics potential and recent advances in drug delivery
Source:
Informa UK Limited
Drug Delivery Systems: Entering the Mainstream
Source:
American Association for the Advancement of Science (AAAS)
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Source:
Massachusetts Medical Society
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
Source:
Springer Nature
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
Source:
Wiley
Bone-targeted methotrexate–alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo
Source:
Taylor & Francis
High-dose methotrexate in adult oncology patients: A case-control study assessing the risk association between drug interactions and methotrexate toxicity
Source:
SAGE Publications
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Osteoclasts in arthritis and Th17 cell development
Source:
Elsevier BV
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
Source:
Springer Nature America, Inc
Bisphosphonates: new therapeutic agents for the treatment of bone tumors
Source:
Elsevier BV
Methotrexate: a detailed review on drug delivery and clinical aspects
Source:
Informa Healthcare
A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis
Source:
Springer Science and Business Media LLC
Tocilizumab–Alendronate Conjugate for Treatment of Rheumatoid Arthritis
Source:
American Chemical Society (ACS)
Small Interfering RNA Knocks Down the Molecular Target of Alendronate, Farnesyl Pyrophosphate Synthase, in Osteoclast and Osteoblast Cultures
Source:
American Chemical Society (ACS)
Phenotypic characterization of type II collagen-induced arthritis in Wistar rats
Source:
Spandidos Publications
Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate
Source:
American Medical Association (AMA)
Bone-targeted methotrexate–alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo
Source:
Taylor & Francis
The Study of Mechanisms of Protective Effect of Rg1 against Arthritis by Inhibiting Osteoclast Differentiation and Maturation in CIA Mice
Source:
Hindawi Limited
Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug
Source:
Ivyspring International Publisher
Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis
Source:
American Association for the Advancement of Science (AAAS)
A hyaluronic acid–methotrexate conjugate for targeted therapy of rheumatoid arthritis
Source:
Royal Society of Chemistry (RSC)
Drug-Related Hepatotoxicity
Source:
Massachusetts Medical Society
Pathogenesis of bone erosions in rheumatoid arthritis
Source:
Ovid Technologies (Wolters Kluwer Health)
Drug-Related Hepatotoxicity
Source:
Massachusetts Medical Society
Osteoclasts are essential for TNF-α–mediated joint destruction
Source:
American Society for Clinical Investigation
Pathogenesis of bone erosions in rheumatoid arthritis
Source:
Ovid Technologies (Wolters Kluwer Health)
Osteoclasts are essential for TNF-α–mediated joint destruction
Source:
American Society for Clinical Investigation
Rheumatoid arthritis market
Source:
Springer Nature
Osteoclasts are essential for TNF-α–mediated joint destruction
Source:
American Society for Clinical Investigation
Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice
Source:
Springer Science and Business Media LLC
Linking provided by
